A weekly e-journal by Art Epstein, OD, FAAO

#########

Volume 18, Number 17

Monday, April 24, 2017

#########

Inside this issue: (click heading to view article)
#########
######### Off the Cuff: Embrace Technology or Die
#########
######### Water Exposure is a Common Risk Behavior Among Contact Lens Wearers
#########
######### Prevalence of Depression & Depressive Symptoms Among Eye Disease Patients
#########
######### Risk Factors For Bleb-related Infection Following Trabeculectomy Surgery
#########
######### News & Notes
 

Click on the image for upcoming Conferences and Meetings.
http://www.facebook.com/pages/Optometric-Physician/256126944408439

 

Off the Cuff: Embrace Technology or Die

Last week, I sounded a warning about how emerging and potentially dangerous technology is being forced down an unsuspecting public’s throat. 1-800 Contacts and Opternative, funded by venture capitalists, are waging a war on optometry using an army of PR flacks and strategists. With an additional eight million in funding, expect Simple Contacts to join the fray.

After a good deal of thought, I’ve concluded that the only way we can protect our patients and profession is to beat them at their own game. We can’t just embrace this technology; we must own it, refine it and use it more effectively than they do.

Current online refractive technology is rudimentary at best. We can do better. Our schools and colleges of optometry have some of the best vision scientists in the world, and we are supported by a massive and diverse industry dedicated to patient care. We can and should own this.

We have the relationships and the emotional connection to our patients. We are committed to placing patient well-being above all else. An ophthalmologist rubber-stamping a refraction for some extra pocket change, without ever seeing the patient, is not what any of us would describe as acceptable patient care.

This is not a time for us to be complacent or in denial—it’s time to act. We can perfect and integrate telemedicine into our existing practices for patients when medically appropriate.

This menace won’t go away by itself, and effectively countering it won’t happen without significant effort, determination and leadership. We must work together with common purpose and we must start now. We can lie down, roll over and eventually cease to exist as a viable independent profession; or, we can fight fire with fire. Anyone have a light?  

 


Arthur B. Epstein, OD, FAAO
Chief Medical Editor
artepstein@optometricphysician.com

 

Want to share your perspective? Write to Dr. Epstein at artepstein@optometricphysician.com.

The views expressed in this editorial are solely those of the author and do not necessarily represent the opinions of the editorial board, Jobson Medical Information LLC (JMI), or any other entities or individuals.

 



Advertisement

Water Exposure is a Common Risk Behavior Among Contact Lens Wearers
 
 
This study was conducted to understand soft contact lens (SCL) and gas-permeable (GP) lens wearers' behaviors and knowledge regarding exposure of lenses to water. The Contact Lens Risk Survey (CLRS) and health behavior questions were completed online by a convenience sample of 1,056 SCL and 85 GP lens wearers ages 20 to 76 years. Participants were asked about exposing their lenses to water and their understanding of risks associated with these behaviors. Chi-square analyses examined relationships between patient behaviors and perceptions.

GP lens wearers were more likely than SCL wearers to rinse or store lenses in water (rinsing: 91% GP, 31% SCL; storing: 33% GP, 15% SCL). Among SCL wearers, men were more likely to store (24% vs. 13%) or rinse (41% vs. 29%) their lenses in water. Showering while wearing lenses was more common in SCL wearers (86%) than GP lens wearers (67%). Swimming while wearing lenses was reported by 62% of SCL wearers and 48% of GP lens wearers. Wearers who rinsed or stored lenses in water reported that this behavior had little or no effect on their infection risk compared with those who did not. Both SCL and GP lens wearers perceived that distilled water was safer than tap water for storing or rinsing lenses.

Despite previously published evidence of Acanthamoeba keratitis's association with water exposure, most SCL, and nearly all GP, lens wearers regularly exposed their lenses to water, with many unaware of the risk.


SOURCE: Zimmerman AB, Richdale K, Mitchell GL, et al. water exposure is a common risk behavior among soft and gas-permeable contact lens wearers. Cornea. 2017; Apr 13. [Epub ahead of print].






Prevalence of Depression & Depressive Symptoms Among Eye Disease Patients
 
 
The prevalence of depression among different eye disease patients varies across studies and has not been systematically reviewed. This study is to provide a summary of the prevalence of depression among eye disease patients. PubMed, Medline, Embase and Cochrane Library were searched from January 1990 to December 2015 to identify studies with information on the prevalence of depression among ophthalmic patients. A random/fixed-effects meta-analysis was used to estimate the pooled prevalence of depression among eye disease patients. Heterogeneity was assessed with the I2 test.

Twenty-eight studies were selected from 3,162 references. The overall pooled prevalence of depression or depressive symptoms with eye disease was 25% (1,502/6,589 individuals) ranging from 5.4% to 57.0%. Regarding different disease categories, the highest prevalence was revealed for dry eye disease (DED) with 29%, followed by 25% for glaucoma patients, 24% for age-related macular degeneration (AMD) patients and 23% for cataract patients.

The increased pooled prevalence of depression was identified in those with eye diseases compared with healthy controls. Substantial heterogeneity was identified across most estimates. Researchers suggested that further research was needed to identify effective strategies for preventing and treating depression among eye disease patients.

SOURCE: Zheng Y, Wu X, Lin X, et al. The prevalence of depression and depressive symptoms among eye disease patients: A systematic review and meta-analysis. Sci Rep. 2017;7:46453.

 

 

Risk Factors For Bleb-related Infection Following Trabeculectomy Surgery
 
 
Bleb-related infection (BRI) is a devastating complication of trabeculectomy surgery. The aim of this study was to identify ocular risk factors for BRI with specific emphasis on ocular surface parameters. It has been suggested that BRI frequency has increased since the introduction of antimetabolites, particularly mitomycin C. As such, researchers conducted a clinical study of BRI following trabeculectomy surgery to investigate risk factors by documenting historical data review from patients records, self-reported questionnaires specific to ocular surface symptoms, and a repeat detailed clinical examination of the lid, ocular surface and tear film.

Twenty-eight cases and 31 controls were assessed. The overwhelming risk factor for development of BRI was chronic blepharitis. No increased risk was identified with the antimetabolite used during trabeculectomy surgery or the type of conjunctival reflection adopted for surgery. Neither age nor dry eyes were identified as risk factors.

An increased risk of BRI was identified in eyes with chronic blepharitis. To minimize the risk of infection following trabeculectomy surgery, researchers wrote that it may be advisable to manage lid disease in these patients prior to performing trabeculectomy surgery or offer an alternative treatment such as a shunt.

SOURCE: Rai PA, Barton K, Murdoch IE. Risk factors for bleb-related infection following trabeculectomy surgery: Ocular surface findings-a case-control study. Br J Ophthalmol. 2016; Oct 18. [Epub ahead of print].



Advertisement



 

News & Notes
 
B+L Program: 180,000-Plus Units of CLs & Blister Packs Recycled
Bausch + Lomb announced that more than 180,000 units of used contact lenses and blister packs have been recycled through the Bausch + Lomb One by One Recycling Program. To date, more than 1,800 optometry offices have signed up to participate in the free program, developed by Bausch + Lomb in collaboration with TerraCycle, a recycling company. On Earth Day on April 18, Bausch + Lomb educated consumers about the program during a celebration hosted by Earth Day Initiative. For each pound of waste recycled through the program, Bausch + Lomb makes a $1 donation to Optometry Giving Sight. Read more.

LA County DHS Study Demonstrates Increase in DR Screenings
A study by the Los Angeles County Department of Health Services, published in the March 2017 issue of JAMA Internal Medicine, revealed that a telemedicine-based diabetic retinopathy screening program utilizing the eConsult system, developed by Safety Net Connect, was a promising and sustainable intervention for improving access to diabetic eye care for underinsured and uninsured individuals. Among a subset of 21,222 individuals who participated in the program between September 2013 and December 2015, pre-program and post-program data comparisons revealed a significant increase in specialty eye care access. Wait times for screening decreased by 89.2 percent (from 158 to 17 days), and overall annual DR screening rates increased by 16 percent (from 40.6 percent to 56.9 percent). Read more.

FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for DR
Genentech announced that the U.S. Food and Drug Administration approved Lucentis (ranibizumab injection) 0.3 mg for the monthly treatment of all forms of diabetic retinopathy. With this approval, Lucentis becomes the first FDA-approved therapy to treat diabetic retinopathy in individuals who have been diagnosed with or without diabetic macular edema. In February 2015, Lucentis received FDA approval for the treatment of DR in people with DME based on data from the RIDE and RISE Phase III clinical trials. The FDA granted Lucentis Priority Review for the treatment of DR without DME based on an analysis of the Diabetic Retinopathy Clinical Research Network’s Protocol S study. This NIH-funded study compared Lucentis treatment with panretinal laser treatment in DR subjects with and without DME. In the analysis supporting approval, individuals with and without DME in the Lucentis group experienced improvements in the severity of their retinopathy. Adverse events were consistent with those seen in previous studies. Read more.

 

 

 
New Technologies and Treatments in Eye Care 2017 - Orlando, Florido


   
 
   

Optometric Physician™ Editorial Board
 

Chief Medical Editor
Arthur B. Epstein, OD, FAAO

Journal Reviews
Shannon Steinhäuser, OD, FAAO


Contributing Editors
• Katherine M. Mastrota, MS, OD, FAAO
• Barry A. Weissman, OD, PhD, FAAO (Dip CL)

Editorial Board
• William Jones, OD, FAAO
• Alan G. Kabat, OD, FAAO
• Bruce Onofrey, RPh, OD, FAAO
• John Schachet, OD, FIOS
• Joseph Shovlin, OD, FAAO


 

 

Optometric Physician™ (OP) newsletter is owned and published by Dr. Arthur Epstein. It is distributed by the Review Group, a Division of Jobson Medical Information LLC (JMI), 11 Campus Boulevard, Newtown Square, PA 19073.

To change your email address, reply to this email. Write "change of address" in the subject line. Make sure to provide us with your old and new address.

To ensure delivery, please be sure to add Optometricphysician@jobsonmail.com to your address book or safe senders list.

Click here if you do not want to receive future emails from Optometric Physician.

HOW TO SUBMIT NEWS
E-mail optometricphysician@jobson.com or FAX your news to: 610.492.1039.

HOW TO ADVERTISE
For information on advertising in this e-mail newsletter or other creative advertising opportunities with Optometric Physician, please click here for advertising information.